Loading...
Symbols:
Loading...
Symbols:
Acorda Therapeutics Inc. (ACOR)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Acorda Therapeutics Inc. (ACOR)
13 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on ACOR
- Lon Juricic(5)
- SA Editor Miriam Metzinger(3)
- Centient Biotech Investor(3)
- H.S. Ayoub(1)
- Anthony Payne(1)
Most popular authors
(tracked in watchlists)
- SA Editor Miriam Metzinger(95)
- Option Dragon(48)
- Eben Tessari (19)
- Lon Juricic(15)
- H.S. Ayoub(3)
Most commented on authors
- Option Dragon(10)
- Eben Tessari (7)
- SA Editor Miriam Metzinger(0)
- Lon Juricic(0)
- H.S. Ayoub(0)
- A Biotech Bloom in July
- MS Drug Fampridine Sends Acorda Stock Way Up
- Icahn's Hedge Fund Has New Stakes In Genzyme and Childrens Place, Among Others
- Acorda Therapeutics: Sell or Short?
- Loeb's Third Point Issues Latest 13F: Summary of Holdings
- Loeb's Third Point LLC Lowering Its Stake in Acorda
- Biotech Week in Review: Holding Steady
- Activist Hedge Fund Seeks Sale of Acorda
- Acorda Therapeutics Responds to Loeb's Sale Suggestion
- Acorda Therapeutics: Loeb's Third Point Urges Sale of Company
- Eye on Acorda Therapeutics
- 2007: The Year Of Biotech IPOs?
- Acorda Proves That Biotech Investing is Volatile, Unpredictable and Dangerous
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »